Advertisement
SIROCCO stands for "Silencing RNAs: organisers and coordinators ofcomplexity in eukaryotic organisms". InteRNA will join for the remaining 2.5years of this EUR 11.8 million funded four-year Integrated Project under theEU Sixth Framework Programme.
Advertisement
InteRNA's contribution will focus on discovery, data mining anddevelopment of diagnostic miRNA and other small RNA profiles throughnext-generation sequencing, in combination with InteRNA's proprietary smallRNA bioinformatics pipeline, miR-Intess(TM), of diverse patient sample setsprovided by consortium members and other sources.
"Pleased as we were by the invitation to become a partner in the SIROCCOconsortium, we are very excited that we now can participate in this uniquesmall RNA consortium as it will further support the progression of ourdiscovery and development programs," said Roel Schaapveld, Chief OperatingOfficer of InteRNA Technologies.
About InteRNA Technologies B.V.
InteRNA Technologies B.V. actively explores and exploits opportunities totranslate its unique collection of miRNAs and miRNA discovery and validationtechnologies into successful diagnostic, prognostic and therapeuticapplications. The company's primary focus is to unravel the role of itsproprietary miRNAs in cancer.
InteRNA Technologies was incorporated in 2006 by Aglaia Oncology Fund andhas established close relationships with the leading miRNA research groups ofits founders Edwin Cuppen, PhD, and Eugene Berezikov, PhD.
See for more information http://www.interna-technologies.com.
For further information on the SIROCCO project, please visithttp://www.sirocco-project.eu.
SOURCE InteRNA Technologies BV